News & Press
Edition 1 / March 2021
Peptides, Lipids & Carbohydrates Platform > The Role of Lipids in mRNA Vaccine Production
Edition 1 / March 2021
Author
Dr. Matthieu Giraud
Director, Global Peptides, Lipids & Carbohydrates Platform
CordenPharma International
Lipid NanoParticle (LNP) delivery systems are a proven strategy for mRNA vaccine development. CordenPharma diligently supports global partners to supply the highly pure, critical excipients they require for formulation.
In response to the COVID-19 pandemic, mRNA (messenger RNA) vaccines have catapulted to center stage of the pharmaceutical and biotechnology industry. As of early 2021, there are eight ongoing human trials for mRNA vaccines led by Moderna, BioNTech / Pfizer, CureVac, Sanofi / TranslateBio, Arcturus / Duke-NUS Medical School (Singapore), Imperial College (London), Chulalongkorn University (Thailand), and Providence Therapeutics.
In terms of SARS-CoV-2 infection in 2020, two of these clinical trials announced interim phase 3 results that reported an efficacy of greater than 94% reduction of infection after the administration of 2 doses (30 μg for Pfizer/BioNtech or 100 μg for Moderna). Both vaccines were developed using an mRNA sequence that encodes for a spike protein immunogen, delivered in a Lipid NanoParticle (LNP).
Through a process known as transcription, an RNA copy of a DNA sequence is made which creates a given protein. This copy – now called mRNA (messenger RNA) – travels from the nucleus of the cell to the part of the cell known as the cytoplasm, which houses ribosomes. Ribosomes are complex machinery in the cells that are responsible for making proteins. Then, through another process known as translation, ribosomes ‘read’ the mRNA, and follow the instructions, creating the protein step by step. The cell then expresses the protein (the Spike Glycoprotein, in the case of the coronavirus SARS-CoV-2) and it, in turn, carries out its designated function in the cell or body.
Coronavirus SARS-CoV-2 structure with Spike Glycoprotein “Girl with balloon” – Free inspiration from Banksy by M.Giraud, May 2020
The Spike (S) Glycoprotein of SARS-CoV-2, which plays a key role in the receptor recognition and cell membrane fusion process, is composed of two subunits, S1 and S2. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. With a size of 180–200 kDa, the S protein consists of an extracellular N-terminus, a transmembrane (TM) domain anchored in the viral membrane, and a short intracellular C-terminal segment.
The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of Lipid NanoParticle (LNP) delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play a role as adjuvants and in vaccine reactogenicity.
LNP as a vehicle to support mRNA delivery. (CordenPharma Image)
1) Role of Cationic Lipids
Cationic Lipids are critical to the self-assembly process of the Lipid NanoParticle itself, the ability of it to be introduced (or inserted or enter or travel) into cells, and the escape of the mRNA from the endosome. They are the functional lipid components of the Drug Product.
When incorporated into Lipid NanoParticles (LNP), they help regulate the endosomal release of the RNA. During Drug Product manufacturing, introduction of an aqueous mRNA solution to an ethanolic lipid mixture containing the Cationic Lipid at a specific pH leads to an electrostatic interaction between the negatively charged RNA backbone and the positively charged Cationic Lipid, which then leads to the encapsulation of the RNA Drug Substance, resulting in particle formation. Once the Lipid NanoParticle has been introduced into the cell, the low pH of the endosome renders the Lipid NanoParticle (LNP) fusogenic, allowing the release of RNA into the cytosol.
Typical examples of Cationic Lipids are:
2) Role of Phospholipids
The Phospholipid component provides a stable bilayer-forming structure to balance the non-bilayer propensity of the Cationic Lipid, eventually forming a stable bilayer underneath the PEG surface. Examples include:
3) Role of Cholesterol
Cholesterol stabilizes the Lipid NanoParticle (LNP) structures and facilitates endosome escape. The major source of cholesterol today comes from the wool grease of sheep.
In 2011, EMA published a revised guidance to minimize the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3). Transmissible Spongiform Encephalopathies (TSEs) are chronic degenerative nervous diseases characterised by the accumulation of an abnormal isoform of a cellular glycoprotein.
TSE Diseases in Animals include:
At CordenPharma, we only manufacture non-animal origin cholesterol, called CP BotaniChol, with a synthesis process that starts from plant derivative materials that are chemically converted into the final cholesterol. With such an approach, we avoid any potential animal source of contamination. CordenPharma is a trusted and reliable source of gram and bulk (Kg, MT) supply of this vegetal-derived Cholesterol in GMP grade, suitable for parenteral use, but not exclusively.
CP BotaniChol (Non-animal origin Cholesterol) manufacturing at CordenPharma.
(CordenPharma Image)
4) Role of PEG Lipids
The primary function of PEGylated Lipid is to form a protective hydrophilic layer that sterically stabilises the LNP, which contributes to storage stability, reduces nonspecific binding to proteins, and prolongs the circulation time after in vivo administration. Because higher PEG content reduces cellular uptake and interaction with the endosomal membrane, PEG content should be very well controlled. Examples include:
At CordenPharma, PEGylated lipids are currently produced at large-scale, allowing MT kg annual delivery worldwide.
The entire CordenPharma organization is honored to support the emergence of these synthetic mRNA-based vaccines with long-standing expertise in the manufacture & supply of specialized critical Lipid excipients and components. We look forward to the great strides the Pharma Industry is making over the coming months and years to provide life-saving vaccines and critical medications to patients.
Stay up to date with the latest thought leadership articles and news from CordenPharma.
Essential cookies are required for basic website functions. This ensures that the website functions properly
The technical storage or access that is used exclusively for statistical purposes.
Name | _ga |
---|---|
Provider | google-analytics.com |
Purpose | This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports. |
Cookie life cycle | 2 years |
Name | _gid |
---|---|
Provider | google-analytics.com |
Purpose | This cookie is set by Google Analytics. It stores and update a unique value for each page visited and is used to count and track pageviews. |
Cookie life cycle | 1 Day |
Name | collect |
---|---|
Provider | google-analytics.com |
Purpose | "Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels. |
Cookie life cycle | session |
Name | vuid |
---|---|
Provider | vimeo.com |
Purpose | Collects data on the user's visits to the website, such as which pages have been read. These cookies are used by the Vimeo video player on websites. |
Cookie life cycle | 2 years |
Name | BE_CLA3 |
---|---|
Provider | BrightEdge |
Purpose | Enables data aggregation, analysis and report creation to assess marketing effectiveness and for website performance. |
Cookie life cycle | 37199 days |
Name | YSC |
---|---|
Provider | Youtube |
Purpose | This cookie is set by YouTube to track views of embedded videos. |
Cookie life cycle | session |
Name | __utmc |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. It is not used in most sites but is set to enable interoperability with the older version of Google Analytics code known as Urchin. In this older versions this was used in combination with the __utmb cookie to identify new sessions/visits for returning visitors. When used by Google Analytics this is always a Session cookie which is destroyed when the user closes their browser. Where it is seen as a Persistent cookie it is therefore likely to be a different technology setting the cookie. |
Cookie life cycle | Session |
Name | __utma |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. This cookie lasts for 2 years by default and distinguishes between users and sessions. It it used to calculate new and returning visitor statistics. The cookie is updated every time data is sent to Google Analytics. The lifespan of the cookie can be customised by website owners. |
Cookie life cycle | 2 years |
Name | __utmz |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour measure of site performance. This cookie identifies the source of traffic to the site - so Google Analytics can tell site owners where visitors came from when arriving on the site. The cookie has a life span of 6 months and is updated every time data is sent to Google Analytics. |
Cookie life cycle | 6 months 2 days |
Name | __utmb |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour measure of site performance. This cookie identifies the source of traffic to the site - so Google Analytics can tell site owners where visitors came from when arriving on the site. The cookie has a life span of 6 months and is updated every time data is sent to Google Analytics. |
Cookie life cycle | 6 months 2 days |
Name | __utmt |
---|---|
Provider | google-analytics.com |
Purpose | This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. This cookie determines new sessions and visits and expires after 30 minutes. The cookie is updated every time data is sent to Google Analytics. Any activity by a user within the 30 minute life span will count as a single visit, even if the user leaves and then returns to the site. A return after 30 minutes will count as a new visit, but a returning visitor. |
Cookie life cycle | 30 minutes |
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Name | visitor_id# |
---|---|
Provider | pardot.com |
Purpose | "Used in context with Account-Based-Marketing (ABM). The cookie registers data such as IP-addresses, time spent on the website and page requests for the visit. This is used for retargeting of multiple users rooting from the same IP addresses. ABM usually facilitates B2B marketing purposes." |
Cookie life cycle | 10 years |
Name | visitor_id#-hash |
---|---|
Provider | pardot.com |
Purpose | Used to encrypt and contain visitor data. This is necessary for the security of the user data. |
Cookie life cycle | 10 years |
Name | Google Maps API |
---|---|
Provider | Google Maps |
Purpose | to read user IP address. |
Cookie life cycle | expires immediately |
Name | GPS |
---|---|
Provider | Youtube |
Purpose | YouTube is a Google owned platform for hosting and sharing videos. YouTube collects user data through videos embedded in websites, which is aggregated with profile data from other Google services in order to display targeted advertising to web visitors across a broad range of their own and other websites. |
Cookie life cycle | session |
Name | PREF |
---|---|
Provider | Youtube |
Purpose | This cookie, which may be set by Google or Doubleclick, may be used by advertising partners to build a profile of interests to show relevant ads on other sites. It works by uniquely identifying your browser and device. |
Cookie life cycle | 8 months |
Name | VISITOR_INFO1_LIVE |
---|---|
Provider | Youtube |
Purpose | This cookie is set by Youtube to keep track of user preferences for Youtube videos embedded in sites;it can also determine whether the website visitor is using the new or old version of the Youtube interface. |
Cookie life cycle | 6 months |
#CordenPharmaBoulder #CordenPharmaColorado
Celebrations included a garden party with a festive banquet of foods from Italy, Germany, France, & US, games, marshmallow roasting, custom beer steins and other 15 Year gifts, and balloons stuffed with prizes. All employees then heard a speech from Managing Director Brian McCudden and COO Dr. Lee Newton.
#CordenPharmaBergamo
Celebrations included a garden party with German-themed breakfast, lunch or dinner buffets, 15 Year custom cakes and gifts distributed to all employees, along with a speech from Managing Director Luca Porcu and VP of Platform Management & Marketing Stephen Houldsworth.
#CordenPharmaSwitzerland
Celebrations included an introduction of our core values, followed by playful games to implement them, distribution of 15 year bags, food and a live band in a garden party. Employees heard from Managing Director Dr. Juerg Burger and VP of Human Resources Stefanie Gerber.
#CordenPharmaPlankstadt
Celebrations were split into 3 groups to cover all shifts and included a festive room with a 3 course buffet meal, 15 Year custom gift bags with locally-brewed beer, and a welcome speech by Site Business Development Christina Simons and CEO Dr. Michael Quirmbach.
#CordenPharmaFrankfurt
Celebrations included a garden party with food trucks, table games, a pub quiz with team prizes, instant cameras for a photo collage, and 15 Year gifts. Guests included the CPI Global Compliance Team, Allessa GmbH, Weylchem Innotec GmbH, and Walter Krebs GmbH, with speeches by Head of Operations Dr. Karsten Meyenberg and CFO Heiko Serwe.
#CordenPharmaChenôve
Celebrations included a garden party with a “Burgundy” aperitif dinner, food trucks for lunch, a fun photo booth for taking 15 Year souvenirs, and speeches by Managing Director Yves Michon and CordenPharma Chief Quality & Compliance Officer Will Cashin.
#CordenPharmaCaponago
Celebrations continued 4 times throughout the day & night to cover all shifts, and included a multi-course German lunch or dinner with brezel, speeches by Managing Director Fabrizio Fiordigiglio and VP of Sales Dr. Mimoun Ayoub, followed by a festive garden gazebo for the 15 Year gift distribution of Prosecco and backpacks.
#CordenPharmaBrussels
Celebrations included a boat ride to Brussels City Center, followed by 3 groups taking guided bike or walking tours of secret places along the canal or the Tour & Taxis building. The party finished with a BBQ dinner and speeches from Managing Director Dr. Jean-Luc Dewez and VP General Counsel Nicolas Reischer.
Brittany Hayes joined CordenPharma as Director, Global Highly Potent & Oncology Platform in October 2021, bringing over 20 years of extensive experience in the areas of contract manufacturing (Drug Substance & Drug Product), pharmaceutical and API development, business development, contract management, and organic chemistry.
Prior to joining CordenPharma, Brittany held leadership positions at various Contract Development & Manufacturing Organizations (CDMOs) including Recro, Regis Technologies, DSM/Patheon/Thermo Fisher, Formex, Ricerca, and Azopharma. Most recently, Brittany was Applied Technology Director at Recro, where she was responsible for managing the proposal evaluations and development team, providing technical support to the BD team, creating training for new service offerings, and enhancing new client onboarding & knowledge transfer by liaising with business development executives, technical operations personnel, and project managers. Brittany excels at driving technical decision-making for successful pharmaceutical product development.
Brittany earned her Ph.D. in organic chemistry from Wake Forest University (Winston-Salem, NC) and her B.S. degree in Chemistry from Emory University (Atlanta, GA). She also was an American Heart Association postdoctoral fellow at the University of Illinois at Chicago, Department of Medicinal Chemistry & Pharmacognosy. Brittany has been an active member of the American Chemical Society since 1995.